AZD2811: Clinical Trials

2 trials of AZD2811, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Terminated 1

Follow AZD2811: new trials by email Literature Review of AZD2811 trials Research Report on AZD2811

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of AZD2811 + Durvalumab in ES-SCLC
Durvalumab, AZD2811, Carboplatin - Small-Cell Lung Cancer
Phase 2Active not recruitingAstraZeneca312021-02-232026-07-06
AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]
AZD2811 - Small Cell Lung Cancer
Phase 2TerminatedSamsung Medical Center152017-12-012018-11-27

Conditions studied

Small Cell Lung Carcinoma (2)

Sponsors

AstraZeneca (1)  ·  Samsung Medical Center (1)

Countries

South Korea (2)  ·  Poland (1)  ·  Spain (1)  ·  United States (1)